Systemic Mastocytosis - a Diagnostic Challenge

Detalhes bibliográficos
Autor(a) principal: Lladó, AC
Data de Publicação: 2014
Outros Autores: Mihon, C, Silva, M, Galzerano, A
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.17/2108
Resumo: Mastocytosis refers to a group of disorders characterized by the infiltration of clonally derived mast cells to the skin or extracutaneous tissues resulting in a heterogeneous clinical picture. It is a rare hematologic disorder in all its forms. The exact incidence is unknown; it affects patients of any age and males and females equally. Its molecular pathogenesis is incompletely understood. The clinical features of mastocytosis result from both chronic and episodic mast cell mediator release, signs and symptoms arising from diffuse or focal tissue infiltration, and, occasionally, the presence of an associated non-mast cell clonal hematologic disease. The histopathologic analysis is essential for definitive diagnosis but there is no curative treatment. The authors report a clinical case of a 72-year-old woman with no history of allergies, with bicytopenia, weight loss, and diffuse axial osteolytic lesions. This is a rare clinical case of aggressive systemic mastocytosis for which palliative treatment can improve survival and quality of life. A brief review of the literature about this pathology is also included.
id RCAP_e3560cb39a9929025bc3176c7b795588
oai_identifier_str oai:repositorio.chlc.min-saude.pt:10400.17/2108
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Systemic Mastocytosis - a Diagnostic ChallengeHSAC MEDBiopsyAllergy and ImmunologyBone Marrow CellsMastocytosis refers to a group of disorders characterized by the infiltration of clonally derived mast cells to the skin or extracutaneous tissues resulting in a heterogeneous clinical picture. It is a rare hematologic disorder in all its forms. The exact incidence is unknown; it affects patients of any age and males and females equally. Its molecular pathogenesis is incompletely understood. The clinical features of mastocytosis result from both chronic and episodic mast cell mediator release, signs and symptoms arising from diffuse or focal tissue infiltration, and, occasionally, the presence of an associated non-mast cell clonal hematologic disease. The histopathologic analysis is essential for definitive diagnosis but there is no curative treatment. The authors report a clinical case of a 72-year-old woman with no history of allergies, with bicytopenia, weight loss, and diffuse axial osteolytic lesions. This is a rare clinical case of aggressive systemic mastocytosis for which palliative treatment can improve survival and quality of life. A brief review of the literature about this pathology is also included.Associação Brasileira de Hematologia, Hemoterapia e Terapia CelularRepositório do Centro Hospitalar Universitário de Lisboa Central, EPELladó, ACMihon, CSilva, MGalzerano, A2015-04-17T15:54:57Z20142014-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/2108engRev Bras Hematol Hemoter. 2014 May-Jun;36(3):226-9info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-10T09:34:54Zoai:repositorio.chlc.min-saude.pt:10400.17/2108Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:19:29.961358Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Systemic Mastocytosis - a Diagnostic Challenge
title Systemic Mastocytosis - a Diagnostic Challenge
spellingShingle Systemic Mastocytosis - a Diagnostic Challenge
Lladó, AC
HSAC MED
Biopsy
Allergy and Immunology
Bone Marrow Cells
title_short Systemic Mastocytosis - a Diagnostic Challenge
title_full Systemic Mastocytosis - a Diagnostic Challenge
title_fullStr Systemic Mastocytosis - a Diagnostic Challenge
title_full_unstemmed Systemic Mastocytosis - a Diagnostic Challenge
title_sort Systemic Mastocytosis - a Diagnostic Challenge
author Lladó, AC
author_facet Lladó, AC
Mihon, C
Silva, M
Galzerano, A
author_role author
author2 Mihon, C
Silva, M
Galzerano, A
author2_role author
author
author
dc.contributor.none.fl_str_mv Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE
dc.contributor.author.fl_str_mv Lladó, AC
Mihon, C
Silva, M
Galzerano, A
dc.subject.por.fl_str_mv HSAC MED
Biopsy
Allergy and Immunology
Bone Marrow Cells
topic HSAC MED
Biopsy
Allergy and Immunology
Bone Marrow Cells
description Mastocytosis refers to a group of disorders characterized by the infiltration of clonally derived mast cells to the skin or extracutaneous tissues resulting in a heterogeneous clinical picture. It is a rare hematologic disorder in all its forms. The exact incidence is unknown; it affects patients of any age and males and females equally. Its molecular pathogenesis is incompletely understood. The clinical features of mastocytosis result from both chronic and episodic mast cell mediator release, signs and symptoms arising from diffuse or focal tissue infiltration, and, occasionally, the presence of an associated non-mast cell clonal hematologic disease. The histopathologic analysis is essential for definitive diagnosis but there is no curative treatment. The authors report a clinical case of a 72-year-old woman with no history of allergies, with bicytopenia, weight loss, and diffuse axial osteolytic lesions. This is a rare clinical case of aggressive systemic mastocytosis for which palliative treatment can improve survival and quality of life. A brief review of the literature about this pathology is also included.
publishDate 2014
dc.date.none.fl_str_mv 2014
2014-01-01T00:00:00Z
2015-04-17T15:54:57Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.17/2108
url http://hdl.handle.net/10400.17/2108
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Rev Bras Hematol Hemoter. 2014 May-Jun;36(3):226-9
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular
publisher.none.fl_str_mv Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131292117237760